Radiotherapy in Non Hodgkin Lymphoma: dose
Michela Buglione di Monale, Cattedra di Radioterapia, Università degli studi di Brescia

The right timing for the use of growth factors in the integrated treatment of Hodgkin and non Hodgkin lymphoma
Loredana Costa, Università degli studi di Brescia

Radiotherapy in non Hodgkin lymphoma: Radiotherapy: Volume
Vitaliana De Sanctis, Radioterapia Oncologica Università “La Sapienza”, Roma

Advances in Pathology of Hodgkin and Non-Hodgkin Lymphomas
Fabio Facchetti, Department of Pathology University of Brescia

The reasons to use TBI: from Biology to Clinical Applications
Andrea Riccardo Filippi, Radiation Oncology Unit AOU S. Giovanni Battista – Torino, Italy

Radiotherapy: Which Role in Non Hodgkin Indolent Lymphoma?
Stefano Magrini, Università degli studi di Brescia

Bone Marrow Transplantation in Hematologic Malignancies: Hodgkin’s and non Hodgkin’s Lymphomas - Leukemias and Myeloma
Michele Malagola - Chair of Hematology – University of Brescia, Bone Marrow Transplant Unit – AO Spedali Civili - Brescia

Extranodal NHL: the case of CNS. The role of radiotherapy
Luigi Pirtoli and Marta Vannini, Radiotherapy Unit, Università degli Studi di Siena and Azienda Ospedaliera Universitaria Senese

RT in Hodgkin Lymphoma: Lesser is better?
Philip Poortmans, M.D. Ph.D. Radiation oncologist Tilburg, The Netherlands

Hodgkin Lymphoma: Radiation Volumes
Umberto Ricardi Università di Torino

The Problem of Interpretation and Use of Response Evaluation for Treatment
Dr. Gabriele Simontacchi Prof. Giampaolo Biti - Radiation Oncology Department, Florence University, AOU Careggi - Firenze

Extranodal NHL: the Case of CNS The role of Chemotherapy
Dott.ssa Tucci, S.C. Ematologia Spedali Civili di Brescia

The problem of interpretation and use of response evaluation treatment
Pier Luigi Zinzani Institute of Hematology and Medical Oncology “L. e A. Seràgnoli” University of Bologna, Italy

The role of chemotherapy in follicular lymphomas
Emanuele Zucca, M.D. - Oncology Institute of Southern Switzerland (IOSI) Swiss Group for Clinical Cancer Research (SAKK)